🇺🇸 FDA
Patent

US 11202824

Peptide fragments from filoviruses and their uses

granted A61KA61K2039/58A61K2039/6075

Quick answer

US patent 11202824 (Peptide fragments from filoviruses and their uses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/58, A61K2039/6075, A61K2039/6081, A61K39/12